| RS1568899375 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1568904872 |
SLC13A3
|
Health Risk |
Pathogenic |
Leukoencephalopathy, acute reversible |
| RS1568905451 |
CD40
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS1568906348 |
CD40
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS1568906610 |
GNAS;GNAS-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS1568916986 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1568925507 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1568925523 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1568925719 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1568926472 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1568927501 |
SLC13A3
|
Health Risk |
Pathogenic |
Leukoencephalopathy, acute reversible |
| RS1568927747 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1568927820 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1568928525 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1568928804 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1568928928 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS1568929135 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1568929576 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1568929639 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1568930288 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS1568930411 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1568930426 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1568931397 |
COL6A2
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1B, Ullrich congenital muscular dystrophy 1B |
| RS1568932096 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1568932440 |
CBS
|
Health Risk |
Pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS1568932462 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1568932480 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1568932835 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1568937087 |
SMARCB1
|
Health Risk |
Likely pathogenic |
— |
| RS1568937197 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1568938325 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS1568940442 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS1568940507 |
ZNF341
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 3, autosomal recessive |
| RS1568941635 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1568942232 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS1568944870 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1568945329 |
ZNF341
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 3, autosomal recessive |
| RS1568955379 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1568963037 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 15 |
| RS1568963062 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS1568963596 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 15 |
| RS1568966771 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS1568968051 |
ADA2
|
Health Risk |
Pathogenic |
— |
| RS1568972559 |
TP53RK
|
Health Risk |
Likely pathogenic |
Galloway-Mowat syndrome 4, Galloway-Mowat syndrome 4 |
| RS1568976122 |
CYP24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1568977722 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS1568979622 |
UPB1
|
Health Risk |
Pathogenic |
Deficiency of beta-ureidopropionase, Deficiency of beta-ureidopropionase |
| RS1568985256 |
NDUFS7
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 3 |
| RS1568985955 |
SLC2A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial tortuosity syndrome, Arterial tortuosity syndrome |
| RS1568986041 |
CFAP410
|
Health Risk |
Likely pathogenic |
Retinal dystrophy with or without macular staphyloma, Retinal dystrophy with or without macular staphyloma |
| RS1568986619 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1568988719 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS1568991466 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Epilepsy |
| RS1568991852 |
MAPRE2
|
Health Risk |
Likely pathogenic |
Skin creases, congenital symmetric circumferential |
| RS1568992782 |
CFAP410
|
Health Risk |
Likely pathogenic |
Retinal dystrophy with or without macular staphyloma, Retinal dystrophy with or without macular staphyloma |
| RS1568992973 |
NDUFS7
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 3 |
| RS1568994522 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS1568997118 |
EEF1A2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1568998827 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS1569001972 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569002077 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569002159 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569002296 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569002881 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS1569006250 |
CSTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy, Unverricht-Lundborg syndrome |
| RS1569006974 |
GAMT
|
Health Risk |
Likely pathogenic |
Cerebral creatine deficiency syndrome, Inborn genetic diseases |
| RS1569008655 |
RUNX1
|
Health Risk |
Pathogenic |
Thrombocytopenia, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS1569009004 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569009071 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS1569012755 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1569015549 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudopseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS1569016820 |
KCNB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1569017015 |
KCNB1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1569017025 |
KCNB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1569017045 |
KCNB1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1569017073 |
KCNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1569017114 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1569017123 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1569017143 |
KCNB1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1569017148 |
KCNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1569017160 |
KCNB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1569017174 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1569017205 |
KCNB1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1569017257 |
KCNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epileptic encephalopathy, Neurodevelopmental delay |
| RS1569017337 |
KCNB1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1569020396 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS1569022780 |
TBX1
|
Health Risk |
Pathogenic |
— |
| RS1569024289 |
TMPRSS6
|
Health Risk |
Pathogenic |
Microcytic anemia, Microcytic anemia |
| RS1569025178 |
MRAP
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency 2, Glucocorticoid deficiency 2 |
| RS1569026431 |
ACO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS1569027992 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, 8 conditions |
| RS1569031388 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS1569032751 |
GNAS
|
Health Risk |
Likely pathogenic |
McCune-Albright syndrome, Pseudohypoparathyroidism type 1B |
| RS1569034190 |
TRIOBP
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS1569034200 |
TRIOBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1569036540 |
LSS
|
Health Risk |
Pathogenic |
Alopecia-intellectual disability syndrome 4, Alopecia-intellectual disability syndrome 4 |
| RS1569036773 |
TBX4
|
Health Risk |
Pathogenic |
Coxopodopatellar syndrome, Coxopodopatellar syndrome |
| RS1569037127 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1569039353 |
LSS
|
Health Risk |
Pathogenic |
Hypotrichosis 14, Alopecia-intellectual disability syndrome 4 |
| RS1569040134 |
TRIOBP
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |